Third Study Of Novartis Valsartan Drug Found With Questionable Data
This article was originally published in PharmAsia News
Executive Summary
A third Japan university has declared a Novartis Pharma study based on clinical trials the school conducted for Diovan (valsartan) blood-pressure drug contained questionable data.